Wei, Hai http://orcid.org/0000-0002-7338-4899
Weaver, Yi M. http://orcid.org/0000-0002-8993-2001
Yang, Chendong
Zhang, Yuan http://orcid.org/0000-0002-1199-8828
Hu, Guoli
Karner, Courtney M. http://orcid.org/0000-0003-0387-4486
Sieber, Matthew http://orcid.org/0000-0002-6952-8749
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Weaver, Benjamin P. http://orcid.org/0000-0002-0830-213X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM133755, R01AR076325, R01AR071967, R01AG067604, 2-R35CA220449-07)
Welch Foundation (I-2022-20190330)
Howard Hughes Medical Institute
Article History
Received: 4 May 2023
Accepted: 6 November 2023
First Online: 2 January 2024
Competing interests
: R.J.D. is a founder and advisor for Atavistik Bioscience and an advisor for Agios Pharmaceuticals, Vida Ventures and Droia Ventures. The other authors declare no competing interests.